Skip to main content

Table 4 Correction of general and control variables associated to use of acetyl salicylic acid in primary and secondary prevention.

From: Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain

Correction of logistic model Primary prevention n = 3,273 Secondary prevention n = 867 Total n = 4,140
Variables OR p CI OR p CI OR p CI
Age 1.01 0.011 1.00–1.02 0.98 ns - 1.02 0.000 1.01–1.03
Sex (males) 0.98 ns - 1.04 ns - 0.80 0.006 0.68–0.94
Number of CVRFs 1.14 0.013 1.03–1.27 1.03 ns - 1.16 0.001 1.06–1.26
Total cholesterol 0.89 ns - 1.50 0.039 1.02–2.21 1.30 0.005 1.08–1.55
LDL-C 1.42 0.017 1.06–1.88 0.83 ns - 1.29 0.012 1.04–1.62
Glycated HbA1c 1.51 0.000 1.22–1.89 1.07 ns - 1.47 0.000 1.18–1.79
  1. CVRFs: cardiovascular risk factors; LDL-C: low density lipoprotein cholesterol; OR: odds ratio adjusted by use of acetyl salicylic acid; CI: 95% confidence intervals. Control values incorporated into the final model: total cholesterol (<200 mg/dL), LDL-C (<100 mg/dL), and glycated hemoglobin A1c (<6.5%), p: statistical significance